[go: up one dir, main page]

DK0760848T3 - Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf - Google Patents

Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf

Info

Publication number
DK0760848T3
DK0760848T3 DK95920830T DK95920830T DK0760848T3 DK 0760848 T3 DK0760848 T3 DK 0760848T3 DK 95920830 T DK95920830 T DK 95920830T DK 95920830 T DK95920830 T DK 95920830T DK 0760848 T3 DK0760848 T3 DK 0760848T3
Authority
DK
Denmark
Prior art keywords
compositions
lactobacillus strains
human origin
lactobacillus
strains
Prior art date
Application number
DK95920830T
Other languages
Danish (da)
English (en)
Inventor
Lorenzo Morelli
Vittorio Bottazzi
Luigia Gozzini
Haen Christoph De
Original Assignee
Bracco Spa
Dibra Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0760848(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI941073A external-priority patent/IT1269838B/it
Priority claimed from ITMI941773A external-priority patent/IT1274733B/it
Application filed by Bracco Spa, Dibra Spa filed Critical Bracco Spa
Application granted granted Critical
Publication of DK0760848T3 publication Critical patent/DK0760848T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK95920830T 1994-05-26 1995-05-18 Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf DK0760848T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI941073A IT1269838B (it) 1994-05-26 1994-05-26 Ceppi di lattobacilli di origine umana e loro usi
ITMI941773A IT1274733B (it) 1994-08-25 1994-08-25 Ceppo del genere lactobacillus di origine umana e suoi usi
PCT/EP1995/001886 WO1995033046A1 (fr) 1994-05-26 1995-05-18 Souches de lactobacillus d'origine humaine, leurs compositions et leurs utilisations

Publications (1)

Publication Number Publication Date
DK0760848T3 true DK0760848T3 (da) 1998-09-23

Family

ID=26331139

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95920830T DK0760848T3 (da) 1994-05-26 1995-05-18 Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf

Country Status (18)

Country Link
US (1) US5709857A (fr)
EP (1) EP0760848B1 (fr)
JP (1) JP3653277B2 (fr)
CN (1) CN1094972C (fr)
AT (1) ATE163042T1 (fr)
AU (1) AU686389B2 (fr)
BR (1) BR9507752A (fr)
CA (1) CA2191213C (fr)
DE (2) DE760848T1 (fr)
DK (1) DK0760848T3 (fr)
ES (1) ES2099056T3 (fr)
FI (1) FI119059B (fr)
GR (2) GR970300016T1 (fr)
HU (1) HU220190B (fr)
MX (1) MX9605807A (fr)
NO (1) NO316644B1 (fr)
NZ (1) NZ287420A (fr)
WO (1) WO1995033046A1 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN175495A0 (en) 1995-03-14 1995-04-13 University Of New England, The Method and composition for the prevention of the over production of acid
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
IT1289159B1 (it) 1997-01-08 1998-09-29 Yurta S R L Composizioni farmaceutiche e alimentari a base di batteri del genere acetobacter
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
DK0956858T3 (da) * 1998-04-30 2002-01-28 Vesely Renata Maria Cavaliere Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
CN1244684C (zh) 1999-03-11 2006-03-08 雀巢制品公司 能够预防病原细菌和轮状病毒引起的腹泻的乳杆菌菌株
EP1034787A1 (fr) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Souches de lactobacillus capables de prévenir la diarrhée causée des bactéries pathogènes
EP1034788A1 (fr) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Souches de bacteries lactiques capables de prevenir la diarrhée
US20040105848A1 (en) * 1999-04-30 2004-06-03 Natarajan Ranganathan Enteric dialysis compositions and methods
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
AU2001233529A1 (en) * 2000-02-10 2001-08-20 Andrew W. Bruce Probiotic therapy for newborns
EP1303256B1 (fr) * 2000-06-09 2009-01-07 Baylor College of Medicine Combinaison d'agents antimicrobiens et d'une interference bacterienne servant a enduire des dispositifs medicaux
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US7214370B2 (en) * 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
IL156490A0 (en) 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
NO318426B1 (no) * 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
US8147821B2 (en) * 2002-02-21 2012-04-03 Grain Processing Corporation Method for drying biomaterials
PT1485463E (pt) 2002-03-21 2008-12-30 Bifodan As Estirpes de lactobacillus
WO2006012536A2 (fr) * 2004-07-22 2006-02-02 Ritter Andrew J Procedes et compositions pour le traitement de l'intolerance au lactose
CA2547144C (fr) 2005-05-16 2010-02-02 Grain Processing Corporation Methode de sechage de milieu filtrant epuise
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
PL2016834T3 (pl) * 2007-07-13 2010-04-30 Unilever Nv Produkt żywnościowy zawierający bakterie i sorbitolowy ester kwasu tłuszczowego
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2010008491A2 (fr) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Compositions de lactose ayant une teneur réduite en lactose
KR101003149B1 (ko) * 2008-10-31 2010-12-22 전남대학교산학협력단 병변 치료용 박테리아 기반의 마이크로로봇
EP2206506A1 (fr) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Formulations probiotiques
BRPI1008280A2 (pt) 2009-02-24 2015-08-25 Ritter Pharmaceuticals Inc Formulações prebióticas e métodos mde uso
EP2248908A1 (fr) 2009-05-05 2010-11-10 Eurolactis Group S.A. Micro-organismes probiotiques isolés du lait d'ânesse
US20120087902A1 (en) * 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
WO2011137249A1 (fr) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Formulations prébiotiques et méthodes d'utilisation
EP3424515A3 (fr) 2010-08-04 2019-06-19 Thomas Julius Borody Dispositifs de collecte des selles et leurs möthodes d'utilisation.
MX2013010343A (es) 2011-03-09 2014-04-30 Univ Minnesota Composicion y metodos para el transplante de microbiota de colon.
WO2013176774A1 (fr) 2012-05-25 2013-11-28 Arizona Board Of Regents Marqueurs de microbiome et thérapies pour troubles du spectre autistique
EP2900805B1 (fr) * 2012-09-25 2022-11-23 Aquilón Cyl S.L. Compositions probiotiques et prébiotiques
JP6692897B2 (ja) 2015-05-14 2020-05-13 クレストヴォ・ホールディングス・エルエルシー 便フローラを移植するための組成物、並びにそれを調製及び使用する方法、並びにそれを送達するためのデバイス
HUE058209T2 (hu) 2015-05-22 2022-07-28 Univ Arizona State Módszerek az autizmus spektrum zavar és azzal összefüggõ tünetek kezelésére
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (fr) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions et procédés pour traiter la cholangite sclérosante primitive et des troubles associés
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018187467A1 (fr) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions et méthodes pour traiter la maladie de parkinson (pd) et des troubles associés
WO2018187464A1 (fr) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions et méthodes pour traiter la diverticulite et des troubles associés
CN110996917A (zh) 2017-05-26 2020-04-10 克雷斯顿沃控股公司 包含基于粪便微生物的治疗剂的冻干组合物及其制造和使用方法
AU2018313766A1 (en) 2017-08-07 2020-02-20 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders
MX2022000756A (es) 2019-07-19 2022-03-11 Finch Therapeutics Holdings Llc Metodos y productos para el tratamiento de trastornos gastrointestinales.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
DK0768375T4 (da) * 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier

Also Published As

Publication number Publication date
HU220190B (hu) 2001-11-28
CN1094972C (zh) 2002-11-27
EP0760848A1 (fr) 1997-03-12
CA2191213A1 (fr) 1995-12-07
NO964966L (no) 1997-01-23
FI964681L (fi) 1997-01-08
DE69501591T2 (de) 1998-06-10
AU686389B2 (en) 1998-02-05
US5709857A (en) 1998-01-20
NO316644B1 (no) 2004-03-22
HUT75555A (en) 1997-05-28
ES2099056T1 (es) 1997-05-16
HU9603251D0 (en) 1997-01-28
NO964966D0 (no) 1996-11-22
EP0760848B1 (fr) 1998-02-04
NZ287420A (en) 1997-12-19
MX9605807A (es) 1997-12-31
WO1995033046A1 (fr) 1995-12-07
JP3653277B2 (ja) 2005-05-25
FI119059B (fi) 2008-07-15
BR9507752A (pt) 1997-10-07
ATE163042T1 (de) 1998-02-15
GR970300016T1 (en) 1997-05-31
ES2099056T3 (es) 1998-04-01
CA2191213C (fr) 2008-03-18
DE760848T1 (de) 1997-08-28
GR3026758T3 (en) 1998-07-31
DE69501591D1 (de) 1998-03-12
CN1154715A (zh) 1997-07-16
JPH10500577A (ja) 1998-01-20
AU2613995A (en) 1995-12-21
FI964681A0 (fi) 1996-11-25

Similar Documents

Publication Publication Date Title
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE69905170T2 (de) Thiazolopyrimidinderivate
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
YU15299A (sh) Farmaceutski sastavi
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
ID23374A (id) Halogenopirimidin
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
DK0705100T3 (da) Terapeutiske substituerede guanidiner
NO20031860L (no) Kahalalid F
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
BG100248A (bg) Инхибитори на скваленсинтетаза
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
ATE305517T1 (de) Neurotrypsin
DK0633928T3 (da) Mikroorganismer, deres fremstilling og anvendelse
GR850831B (fr)
DK0656889T3 (da) 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler
NO20005548D0 (no) Mykobakterieinhibitorer
MD980129A (en) Antiherpetic remedy
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
TR199802703T2 (xx) HIV tedavisinde Vx478, Zidov�din, ve/veya 1592U89 i�eren kombinasyonlar�n kullan�m�.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
NO890035D0 (no) Colepteran-aktive mikroorganismer, relaterte insekticid-sammensetninger og fremgangsmaater og anvendelse derav.